1374036-17-5

Upstream product

• 1374036-13-1 (S)-N-((S,Z)-1-((R)-2-(((tert-butyldiphenylsilyl)oxy)methyl)cyclopentylidene)-1-fluoro-3-methylbutan-2-yl)-2-methylpropane-2-sulfinamide 
• 1374036-14-2 ((R,Z)-2-((S)-2-amino-1-fluoro-3-methylbutylidene)cyclopentyl)methanol 
• 1374036-15-3 methyl ((S,Z)-1-fluoro-1-((R)-2-(hydroxymethyl)cyclopentylidene)-3-methylbutan-2-yl)carbamate 
• 4072-67-7 4,4'-bis(bromoacetyl)biphenyl 
• 1374036-16-4 (R,Z)-2-((S)-1-fluoro-2-((methoxycarbonyl)amino)-3-methylbutylidene)cyclopentanecarboxylic acid 
• 1374036-12-0 (R,E)-N-((Z)-2-((R)-2-(((tert-butyldiphenylsilyl)oxy)methyl)cyclopentylidene)-2-fluoroethylidene)-2-methylpropane-2-sulfinamide 
• 130733-88-9 2-(((tert-butyldiphenylsilyl)oxy)methyl)cyclopentan-1-one 

Downstream Products

• 1374104-92-3 C₄₂H₅₀F₂N₆O₄ 

Relevant academic research and scientific papers

Inhibition of hepatitis C virus NS5A by fluoro-olefin based γ-turn mimetics

The HCV non-structural protein NS5A has been established as a viable target for the development of direct acting antiviral therapy. From computational modeling studies strong intra-molecular hydrogen bonds were found to be a common structural moiety withi